https://ir.castlebiosciences.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/castlebiosciences/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management Wed, 30 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus Mon, 28 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx Thu, 24 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx https://ir.castlebiosciences.com/news-events/press-releases/detail/482/castle-biosciences-to-open-new-laboratory-facility-in-scottsdale Tue, 22 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/482/castle-biosciences-to-open-new-laboratory-facility-in-scottsdale https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus Tue, 15 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc Wed, 09 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences Thu, 20 Aug 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences https://ir.castlebiosciences.com/news-events/press-releases/detail/478/castle-biosciences-approved-for-dual-listing-on-nasdaq-texas Mon, 17 Aug 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/478/castle-biosciences-approved-for-dual-listing-on-nasdaq-texas https://ir.castlebiosciences.com/news-events/press-releases/detail/477/castle-biosciences-reports-second-quarter-2026-results Thu, 30 Jul 26 16:05:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/477/castle-biosciences-reports-second-quarter-2026-results https://ir.castlebiosciences.com/news-events/press-releases/detail/476/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference Wed, 22 Jul 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/476/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference